Dipyridamole

Alternative names

(R)-limonene 6-monooxygenase, (S)-limonene 6-monooxygenase, (S)-limonene 7-monooxygenase, 1,8-cineole 2-exo-monooxygenase, 2EL, 5''-cyclic phosphodiesterase, 5''-cyclic phosphodiesterase 10A, 5''-cyclic phosphodiesterase 4B, 5''-cyclic phosphodiesterase 4C, 5''-cyclic phosphodiesterase 4D, 5''-cyclic phosphodiesterase 7A, 5''-cyclic phosphodiesterase subunit alpha, 5''-cyclic phosphodiesterase subunit alpha'', 5''-cyclic phosphodiesterase subunit beta, 5''-cyclic phosphodiesterase subunit delta, 5''-cyclic phosphodiesterase subunit gamma, 5''-cyclic-AMP and -GMP phosphodiesterase 11A, Albendazole monooxygenase, Albendazole sulfoxidase, CGB-PDE, CGPR A, CN5A, CN5N, CNCG_HUMAN, CNRG_HUMAN, COD4, CP2C9_HUMAN, CP33, CP34, CP3A4_HUMAN, CPC12, CPC8, CPC9, CPCJ, CSNB 3, CSNBAD2, CYP2C, CYP2C10, CYP3, CYP3A, CYP3A3, CYP3A4, CYPIIC9, CYPIIIA3, CYPIIIA4, Cone cGMP specific 3' 5' cyclic phosphodiesterase subunit alpha', Cone cGMP-specific 3'', Congenital stationary night blindness 3 autosomal dominant, Cyclic nucleotide phosphodiesterase 11A, Cytochrome P-450MP, Cytochrome P450 2C9, Cytochrome P450 3A3, Cytochrome P450 3A4, Cytochrome P450 HLp, Cytochrome P450 MP-4, Cytochrome P450 MP-8, Cytochrome P450 NF-25, Cytochrome P450 PB-1, Cytochrome P450 family 3 subfamily A polypeptide 4, Cytochrome P450 subfamily IIIA polypeptide 4, Cytochrome P450, family 2, subfamily C, polypeptide 9, Cytochrome P450-PCN1, DKFZp686F2182, DKFZp686M11213, DPDE 1, DPDE2, DPDE3, DPDE4, Dual 3'', Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A, Dunce like phosphodiesterase E3, Equilibrative NBMPR-sensitive nucleoside transporter, Equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporter, Equilibrative nucleoside transporter 1, FLJ11894, FLJ97311, GMP-PDE alpha, GMP-PDE beta, GMP-PDE delta, GMP-PDE gamma, Glucocorticoid inducible P450, HCP 1, HLP, HS90A_HUMAN, HSP 84, HSP 86, HSP 90, HSP 90 b, HSP90A, HSP90AA1, HSP90AB1, HSPC1, HSPC2, HSPCAL1, HSPCAL4, HSPDE 10A, HSPDE4D, Heat shock 86 kDa, Heat shock protein 90kDa alpha cytosolic class A member 1, Heat shock protein 90kDa alpha cytosolic class B member 1, Heat shock protein HSP 90-alpha, Heat shock protein HSP 90-beta, High affinity cAMP specific 3 5 cyclic phosphodiesterase, High affinity cAMP specific 3'5' cyclic phosphodiesterase, High affinity cAMP specific 3'5' cyclic phosphodiesterase 7A, High affinity cAMP-specific 3'', MGC125749, MGC126222, MGC126529, MGC126680, MGC1465, MGC149605, MGC3778, MGC88256, MGC88320, Microsomal monooxygenase, NF 25, Nifedipine oxidase, Nucleoside transporter, Nucleoside transporter, es-type, OTTHUMP00000010652, OTTHUMP00000010653, OTTHUMP00000010654, OTTHUMP00000010656, OTTHUMP00000016506, OTTHUMP00000016507, OTTHUMP00000016508, OTTHUMP00000016509, OTTHUMP00000016510, OTTHUMP00000016511, OTTHUMP00000016512, OTTHUMP00000017267, OTTHUMP00000020135, OTTHUMP00000232365, P2A, P450 III steroid inducible, P450 MP, P450 PB 1, P450 PCN1, P450, family III, P450C2C, P450C3, P450IIC19, P450IIC9, PDE 21, PDE 5, PDE 6, PDE 6 alpha, PDE 6 beta, PDE 6B, PDE 7, PDE D, PDE IVB, PDE V-B1, PDE1/PDE2 yeast human complement of, PDE10_HUMAN, PDE11A1, PDE11_HUMAN, PDE32, PDE4, PDE43, PDE46, PDE4B5, PDE4B_HUMAN, PDE4C_HUMAN, PDE4DN2, PDE4D_HUMAN, PDE5A1, PDE5A_HUMAN, PDE6 alpha prime, PDE6 alpha', PDE6A_HUMAN, PDE6B_HUMAN, PDE6C_HUMAN, PDE6D_HUMAN, PDE6G, PDE71, PDE7A_HUMAN, PDE7B protein, PDEA, PDEA2, PDEB, PDEG, PPNAD2, Phosphodiesterase 10A, Phosphodiesterase 10A1, Phosphodiesterase 11A, Phosphodiesterase 4A, Phosphodiesterase 4B, Phosphodiesterase 4B cAMP specific, Phosphodiesterase 4B, cAMP specific (phosphodiesterase E4 dunce homolog, Drosophila), Phosphodiesterase 4C, Phosphodiesterase 4C cAMP specific, Phosphodiesterase 4C, cAMP specific (phosphodiesterase E1 dunce homolog, Drosophila), Phosphodiesterase 4D cAMP specific (dunce (Drosophila) homolog phosphodiesterase E3), Phosphodiesterase 4D cAMP specific (phosphodiesterase E3 dunce homolog Drosophila), Phosphodiesterase 4D cAMP-specific, Phosphodiesterase 4D, cAMP specific (dunce), Phosphodiesterase 5A, Phosphodiesterase 5A cGMP specific, Phosphodiesterase 6 alpha, Phosphodiesterase 6A, Phosphodiesterase 6A alpha subunit, Phosphodiesterase 6A cGMP specific rod alpha, Phosphodiesterase 6B, Phosphodiesterase 6B cGMP specific rod beta, Phosphodiesterase 6C cGMP specific cone alpha prime, Phosphodiesterase 6D cGMP specific, Phosphodiesterase 6D cGMP specific rod delta, Phosphodiesterase 6G cGMP Specific, Phosphodiesterase 6G cGMP specific rog gamma, Phosphodiesterase 7A, Phosphodiesterase 7B, Phosphodiesterase E1 dunce homolog, Phosphodiesterase E1 dunce homolog Drosophila, Phosphodiesterase isozyme 5, Phosphodiesterase isozyme 7, Phosphodiesterase type 4C, Protein p17, Quinine 3-monooxygenase, RNPDE7B, RP40, RP57, Rd 1, Renal carcinoma antigen NY-REN-38, Retinal Rod Photoreceptor cGMP Phosphodiesterase alpha, Retinal Rod Photoreceptor cGMP Phosphodiesterase gamma, Retinal cone rhodopsin-sensitive cGMP 3'', Retinal rod photoreceptor cGMP phosphodiesterase delta, Retinal rod rhodopsin sensitive cGMP 3' 5' cyclic phosphodiesterase subunit delta, Retinal rod rhodopsin sensitive cGMP 3' 5'vcyclic phosphodiesterase subunit gamma, Retinal rod rhodopsin-sensitive cGMP 3'', Rod cG PDE G, Rod cGMP phosphodiesterase beta subunit, Rod cGMP specific 3' 5' cyclic phosphodiesterase alpha subunit, Rod cGMP specific 3' 5' cyclic phosphodiesterase beta subunit, Rod cGMP-specific 3'', Rolipram insensitive phosphodiesterase type 7, S-mephenytoin 4-hydroxylase, S29A1_HUMAN, STRK1, Slc29a1, Solute carrier family 29 member 1, TM 22, Taurochenodeoxycholate 6-alpha-hydroxylase, Xenobiotic monooxygenase, bA472E5.1, cAMP and cAMP inhibited cGMP 3'5' cyclic phosphodiesterase 10A, cAMP and cAMP-inhibited cGMP 3'', cAMP and cGMP phosphodiesterase 11A, cAMP specific 3 5 cyclic phosphodiesterase 7B, cAMP specific 3' 5' cyclic phosphodiesterase 4C, cAMP specific 3',5' cyclic phosphodiesterase 4D, cAMP specific 3'5' cyclic phosphodiesterase 7B, cAMP specific phosphodiesterase 4D, cAMP specific phosphodiesterase PDE4D6, cAMP-specific 3'', cAMP-specific 3',5'-cyclic phosphodiesterase 4B, cAMP-specific phosphodiesterase-4 B isoform, cGMP binding cGMP specific 3' 5' cyclic nucleotide phosphodiesterase, cGMP binding cGMP specific 35 cyclic nucleotide phosphodiesterase, cGMP binding/cGMP specific phosphodiesterase, cGMP phosphodiesterase 11A, cGMP phosphodiesterase 6C, cGMP specific 3'5' cyclic phosphodiesterase, cGMP specific phosphodiesterase PDE5A2, cGMP specific phosphodiesterase type 5A, cGMP-binding cGMP-specific phosphodiesterase, cGMP-specific 3'', cytochrome P-450 S-mephenytoin 4-hydroxylase, cytochrome P450, subfamily IIIA (niphedipine oxidase), polypeptide 3, cytochrome P450, subfamily IIIA (niphedipine oxidase), polypeptide 4, dunce-like phosphodiesterase E4, equilibrative nitrobenzylmercaptopurine riboside (NBMPR)-sensitive nucleoside transporter, es-type, flavoprotein-linked monooxygenase, p17 protein, pde11a2, solute carrier family 29 (equilibrative nucleoside transporter), member 1, solute carrier family 29 (nucleoside transporters), member 1